Article ; Online: Pathogenic signaling in multiple myeloma.
2022 Volume 49, Issue 1, Page(s) 27–40
Abstract: Multiple myeloma is a common hematological malignancy of plasma cells, the terminally differentiated B cells that secrete antibodies as part of the adaptive immune response. Significant progress has been made in treating multiple myeloma, but this ... ...
Abstract | Multiple myeloma is a common hematological malignancy of plasma cells, the terminally differentiated B cells that secrete antibodies as part of the adaptive immune response. Significant progress has been made in treating multiple myeloma, but this disease remains largely incurable, and most patients will eventually suffer a relapse of disease that becomes refractory to further therapies. Moreover, a portion of patients with multiple myeloma present with disease that is refractory to all treatments from the initial diagnosis, and no current therapeutic approaches can help. Therefore, the task remains to advance new therapeutic strategies to help these vulnerable patients. One strategy to meet this challenge is to unravel the complex web of pathogenic signaling pathways in malignant plasma cells and use this information to design novel precision medicine strategies to assist these patients most at risk. |
---|---|
MeSH term(s) | Humans ; Multiple Myeloma/drug therapy ; Plasma Cells ; Precision Medicine ; Signal Transduction |
Language | English |
Publishing date | 2022-01-20 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 189220-4 |
ISSN | 1532-8708 ; 0093-7754 |
ISSN (online) | 1532-8708 |
ISSN | 0093-7754 |
DOI | 10.1053/j.seminoncol.2022.01.005 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1348: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.